piracetam has been researched along with Edema in 4 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Edema: Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Levetiracetam (200-1000 nmol/paw) produced a significant dose-dependent reduction of the paw inflammatory hyperalgesia and edema induced by carrageenan." | 7.78 | The local peripheral antihyperalgesic effect of levetiracetam and its mechanism of action in an inflammatory pain model. ( Micov, AM; Stepanović-Petrović, RM; Tomić, MA; Ugrešić, ND, 2012) |
| "The effect of piracetam has been studied in experimental models of the inflammatory process--the models of rat's paw oedema and intraperitoneal formalin ascites for the exudative phase and the cotton pellet model for the proliferative phase." | 7.67 | Effect of piracetam in models of experimental inflammation. ( Dushkova, R; Nikolova, M; Petrova, L, 1984) |
| "Levetiracetam (200-1000 nmol/paw) produced a significant dose-dependent reduction of the paw inflammatory hyperalgesia and edema induced by carrageenan." | 3.78 | The local peripheral antihyperalgesic effect of levetiracetam and its mechanism of action in an inflammatory pain model. ( Micov, AM; Stepanović-Petrović, RM; Tomić, MA; Ugrešić, ND, 2012) |
| "The effect of piracetam has been studied in experimental models of the inflammatory process--the models of rat's paw oedema and intraperitoneal formalin ascites for the exudative phase and the cotton pellet model for the proliferative phase." | 3.67 | Effect of piracetam in models of experimental inflammation. ( Dushkova, R; Nikolova, M; Petrova, L, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ooi, WW | 1 |
| Wijemanne, S | 1 |
| Thomas, CB | 1 |
| Quezado, M | 1 |
| Brown, CR | 1 |
| Nash, TE | 1 |
| Stepanović-Petrović, RM | 1 |
| Micov, AM | 1 |
| Tomić, MA | 1 |
| Ugrešić, ND | 1 |
| Altas, E | 1 |
| Ertekin, MV | 1 |
| Kuduban, O | 1 |
| Gundogdu, C | 1 |
| Demirci, E | 1 |
| Sutbeyaz, Y | 1 |
| Nikolova, M | 1 |
| Petrova, L | 1 |
| Dushkova, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical, Laboratory and Imaging Features, Treatment Trends and Long Term Outcomes in Patients With Parenchymal and Extraparenchymal Neurocysticercosis-A Registry Based Study[NCT04706819] | 1,000 participants (Anticipated) | Observational [Patient Registry] | 2021-01-15 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 other studies available for piracetam and Edema
| Article | Year |
|---|---|
Short report: A calcified Taenia solium granuloma associated with recurrent perilesional edema causing refractory seizures: histopathological features.
Topics: Albendazole; Animals; Anthelmintics; Anticonvulsants; Calcinosis; Edema; Granuloma; Humans; Levetira | 2011 |
The local peripheral antihyperalgesic effect of levetiracetam and its mechanism of action in an inflammatory pain model.
Topics: Adenosine A1 Receptor Antagonists; Adrenergic alpha-Antagonists; Anesthetics, Local; Animals; Carrag | 2012 |
Effects of piracetam supplementation on cochlear damage occurring in guinea pigs exposed to irradiation.
Topics: Animals; Cochlea; Disease Models, Animal; Edema; Guinea Pigs; Organ of Corti; Piracetam; Radiation-P | 2006 |
Effect of piracetam in models of experimental inflammation.
Topics: Animals; Anti-Inflammatory Agents; Ascites; Cell Membrane Permeability; Dose-Response Relationship, | 1984 |